Lakeshore Biopharma Co, Stock Total Debt
| LSBPW Stock | 0.04 0.00 0.00% |
LakeShore Biopharma Co, fundamentals help investors to digest information that contributes to LakeShore Biopharma's financial success or failures. It also enables traders to predict the movement of LakeShore Stock. The fundamental analysis module provides a way to measure LakeShore Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LakeShore Biopharma stock.
Total Debt To Capitalization is likely to climb to 0.44 in 2024. LakeShore | Total Debt |
LakeShore Biopharma Co, Company Total Debt Analysis
LakeShore Biopharma's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current LakeShore Biopharma Total Debt | 424.46 M |
Most of LakeShore Biopharma's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LakeShore Biopharma Co, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
LakeShore Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for LakeShore Biopharma is extremely important. It helps to project a fair market value of LakeShore Stock properly, considering its historical fundamentals such as Total Debt. Since LakeShore Biopharma's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of LakeShore Biopharma's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of LakeShore Biopharma's interrelated accounts and indicators.
Click cells to compare fundamentals
LakeShore Total Debt Historical Pattern
Today, most investors in LakeShore Biopharma Stock are looking for potential investment opportunities by analyzing not only static indicators but also various LakeShore Biopharma's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of LakeShore Biopharma total debt as a starting point in their analysis.
LakeShore Biopharma Total Debt |
| Timeline |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
LakeShore Short Long Term Debt Total
Short Long Term Debt Total |
|
Based on the latest financial disclosure, LakeShore Biopharma Co, has a Total Debt of 424.46 M. This is 84.57% lower than that of the Healthcare sector and 30.69% higher than that of the Biotechnology industry. The total debt for all United States stocks is 92.02% higher than that of the company.
LakeShore Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LakeShore Biopharma's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LakeShore Biopharma could also be used in its relative valuation, which is a method of valuing LakeShore Biopharma by comparing valuation metrics of similar companies.LakeShore Biopharma is currently under evaluation in total debt category among its peers.
LakeShore Fundamentals
| Revenue | 573.42 M | ||||
| EBITDA | (368.66 M) | ||||
| Net Income | (433.46 M) | ||||
| Total Debt | 424.46 M | ||||
| Cash Flow From Operations | (295.23 M) | ||||
| Number Of Employees | 758 | ||||
| Total Asset | 1.51 B | ||||
| Retained Earnings | (2.31 B) | ||||
| Working Capital | 100.94 M | ||||
| Net Asset | 1.51 B |
About LakeShore Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LakeShore Biopharma Co,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LakeShore Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LakeShore Biopharma Co, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for LakeShore Stock Analysis
When running LakeShore Biopharma's price analysis, check to measure LakeShore Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LakeShore Biopharma is operating at the current time. Most of LakeShore Biopharma's value examination focuses on studying past and present price action to predict the probability of LakeShore Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LakeShore Biopharma's price. Additionally, you may evaluate how the addition of LakeShore Biopharma to your portfolios can decrease your overall portfolio volatility.